Related Experiment Video
Updated: May 20, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Seizure risk with AVM treatment or conservative management: prospective, population-based study
Colin B Josephson1, Jo J Bhattacharya, Carl E Counsell
1Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Edinburgh, UK.
Brain arteriovenous malformation (AVM) treatment and conservative management show similar seizure risks over five years. This finding applies regardless of how the AVM initially presented, offering crucial insights for patient care.
Area of Science:
- Neurology
- Neurosurgery
- Epidemiology
Background:
- Brain arteriovenous malformations (AVMs) are complex vascular lesions that can lead to serious neurological complications, including seizures and hemorrhage.
- The optimal management strategy for brain AVMs remains a subject of ongoing research, balancing the risks of treatment against the natural history of the condition.
- Epileptic seizures are a common presentation and complication of brain AVMs, significantly impacting patient quality of life.
Purpose of the Study:
- To compare the risk of epileptic seizures in adults undergoing invasive treatment for brain AVMs versus those managed conservatively.
- To evaluate the likelihood of achieving seizure freedom for two years in adults with brain AVMs under different management strategies.
- To analyze seizure risk based on the initial presentation of the brain AVM (hemorrhage, seizure, or incidental finding).
Main Methods:
- A prospective, population-based observational study was conducted in Scotland.
- Data were collected from 1999-2003 for adults newly diagnosed with brain AVMs.
- Annual general practitioner follow-up, patient questionnaires, and medical records surveillance were used to assess seizure risk and freedom over five years.
Main Results:
- No significant difference in the 5-year risk of first or recurrent seizures was observed between AVM treatment and conservative management groups.
- Seizure risk was comparable across both management strategies, irrespective of AVM presentation (intracerebral hemorrhage, seizure, or incidental).
- The chances of achieving 2-year seizure freedom were similar for patients with epilepsy in both the AVM treatment (52%) and conservative management (57%) groups.
Conclusions:
- In this observational study, invasive treatment for brain AVMs did not alter the 5-year risk of seizures compared to conservative management.
- The choice between AVM treatment and conservative management did not significantly impact seizure outcomes, regardless of the initial presentation.
- These findings suggest that conservative management may be a viable option for select patients with brain AVMs, particularly concerning seizure risk.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Seizures ll: Types
Antiepileptic Drugs: Glutamate Antagonists
